Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study of ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluati…
Hereditary Hemorrhagic Telangiectasia (HHT)Osler Weber Rendu Disease
Estimated
~$10 – $8,750
Atavistik Bio, IncNCT07601425
Phase 1
A Phase I Trial of TOR-582, a Topical Sirolimus-based Treatment for Epistaxis in Adults With Hereditary Hemorrhagic Telangiectasia
People with hereditary hemorrhagic telangiectasia (HHT) often experience frequent and severe nosebleeds that can disrupt daily life and lead to anemia, medical…
Hereditary Hemorrhagic Telangiectasia (HHT)Epistaxis
Estimated
~$10 – $6,250
Columbia UniversityNCT07667413